Article thumbnail

Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression

By Li Zhao, Yanli Tang, Zhengrui You, Qixia Wang, Shuwen Liang, Xiaofeng Han, Dekai Qiu, Jue Wei, Yuan Liu, Lei Shen, Xiaoyu Chen, Yanshen Peng, Zhiping Li and Xiong Ma

Abstract

T helper cells that produce IL-17 (Th17 cells) have recently been identified as the third distinct subset of effector T cells. Emerging data suggests that Th17 cells play an important role in the pathogenesis of many liver diseases by regulating innate immunity, adaptive immunity, and autoimmunity. In this study, we examine the role and mechanism of Th17 cells in the pathogenesis of autoimmune hepatitis (AIH). The serum levels of IL-17 and IL-23, as well as the frequency of IL-17+ cells in the liver, were significantly elevated in patients with AIH, compared to other chronic hepatitis and healthy controls. The hepatic expressions of IL-17, IL-23, ROR-γt, IL-6 and IL-1β in patients with AIH were also significantly increased and were associated with increased inflammation and fibrosis. IL-17 induces IL-6 expression via the MAPK signaling pathway in hepatocytes, which, in turn, may further stimulate Th17 cells and forms a positive feedback loop. In conclusion, Th17 cells are key effector T cells that regulate the pathogenesis of AIH, via induction of MAPK dependent hepatic IL-6 expression. Blocking the signaling pathway and interrupting the positive feedback loop are potential therapeutic targets for autoimmune hepatitis

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3079758
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). and liver regeneration.
  2. (2002). Antigenspecific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.
  3. (2006). Autoimmune hepatitis.
  4. (2003). Control of Regulatory T Cell Development by the Transcription Factor
  5. (2002). Diagnosis and treatment of autoimmune hepatitis.
  6. (2000). Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.
  7. (2008). Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
  8. (2006). Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
  9. (2009). Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
  10. (1999). Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
  11. (2007). IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.
  12. (1992). Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
  13. (2004). Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
  14. (2003). Increased expression of interleukin 17 in inflammatory bowel disease.
  15. (2008). Induction and effector functions of T(H)17 cells.
  16. (2008). Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.
  17. (2007). Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation.
  18. (2009). Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
  19. (2008). Interleukin-22, interleukin-17, and other cytokines: a wall is coming down.
  20. (2004). Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways.
  21. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
  22. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
  23. (2003). Regulatory T cells in the control of transplantation tolerance and autoimmunity.
  24. (1999). Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
  25. (2003). Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice.
  26. (2007). Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.
  27. (2007). The impact of autoimmunity on hepatocytes.
  28. (2009). The interleukin-17 pathway is involved in human alcoholic liver disease.